Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
July 25, 2023
0Patent Application Number
166174710
Date Filed
June 4, 2018
0Patent Citations
Patent Citations Received
Patent Primary Examiner
The present disclosure is directed to methods of treating fibrotic conditions by administration of TRβ agonists. The disclosure provides methods wherein the abnormal deposition of extracellular matrix components, such as collagen, keratin, or elastin, is reduced, either through interaction of TRβ agonists with TGF-β-dependent inflammatory pathways, or by other mechanisms, thereby ameliorating fibrotic symptoms.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
